← Back to Search

Vasodilator

Oral Minoxidil for Chemotherapy-Induced Alopecia

Phase < 1
Waitlist Available
Led By Jennifer N Choi, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 weeks
Awards & highlights

Study Summary

This trial is testing whether minoxidil can help regrow hair in people who have lost it due to chemotherapy.

Who is the study for?
This trial is for adults over 18 with permanent hair loss from chemotherapy, finished at least 6 months ago. They must not be pregnant or nursing, agree to use contraception, and have no history of certain conditions like hypotension or hypersensitivity to the drug's components. Those on other alopecia treatments within the last 3 months or current cancer treatment are excluded.Check my eligibility
What is being tested?
The study tests low-dose oral minoxidil for treating permanent hair loss caused by chemotherapy. It's an open-label pilot study, meaning both researchers and participants know what treatment is being given without any comparison group.See study design
What are the potential side effects?
Possible side effects of oral minoxidil may include a drop in blood pressure, skin reactions where the medication is applied, changes in heart rate, fluid retention leading to swelling (edema), and unwanted facial/body hair growth.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in degree of hair regrowth using the Dean Scale
Change in degree of hair regrowth using the IPAQ scale
Secondary outcome measures
Change in quality of life

Trial Design

1Treatment groups
Experimental Treatment
Group I: Minoxidil TreatmentExperimental Treatment1 Intervention
Low dose oral minoxidil

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,592 Previous Clinical Trials
918,028 Total Patients Enrolled
5 Trials studying Alopecia
44 Patients Enrolled for Alopecia
Jennifer N Choi, MDPrincipal InvestigatorNorthwestern University
2 Previous Clinical Trials
16 Total Patients Enrolled

Media Library

Oral Minoxidil (Vasodilator) Clinical Trial Eligibility Overview. Trial Name: NCT03831334 — Phase < 1
Alopecia Research Study Groups: Minoxidil Treatment
Alopecia Clinical Trial 2023: Oral Minoxidil Highlights & Side Effects. Trial Name: NCT03831334 — Phase < 1
Oral Minoxidil (Vasodilator) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03831334 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New Jersey
Texas
Illinois
How old are they?
18 - 65
What site did they apply to?
Northwestern University
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Recent research and studies
clinicaltrials.govStudy
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia
Jennifer Nam Choi, MD 2019. "Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03831334.
All > Androgenetic Alopecia > Alopecia Areata
~0 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top